From: Combining renal cell arrest and damage biomarkers to predict progressive AKI in patient with sepsis
Outcomes | AUC | 95%CI |
---|---|---|
AKI progression | ||
 u[TIMP-2]*[IGFBP7] | 0.745 | 0.667 to 0.823 |
 u[TIMP-2]*[IGFBP7] + APACHE II | 0.779 | 0.706 to 0.852 |
 u[TIMP-2]*[IGFBP7]] + SOFA | 0.752 | 0.675 to 0.829 |
 u[TIMP-2]*[IGFBP7] + SCr at time of AKI diagnosis | 0.752 | 0.675 to 0.829 |
 u[TIMP-2]*[IGFBP7] + SCys-C at time of AKI diagnosis | 0.754 | 0.677 to 0.831 |
 u[TIMP-2]*[IGFBP7] + Ma | 0.797 | 0.726 to 0.867 |
 u[TIMP-2]*[IGFBP7] + uKIM-1 + M | 0.806 | 0.738 to 0.874 |
AKI progression with death | ||
 u[TIMP-2]*[IGFBP7] | 0.777 | 0.700 to 0.854 |
 u[TIMP-2]*[IGFBP7] + APACHE II | 0.828 | 0.760 to 0.897 |
 u[TIMP-2]*[IGFBP7]] + SOFA | 0.797 | 0.723 to 0.871 |
 u[TIMP-2]*[IGFBP7] + SCr at time of AKI diagnosis | 0.784 | 0.708 to 0.860 |
 u[TIMP-2]*[IGFBP7] + SCys-C at time of AKI diagnosis | 0.785 | 0.708 to 0.861 |
 u[TIMP-2]*[IGFBP7] + M | 0.845 | 0.780 to 0.910 |
 u[TIMP-2]*[IGFBP7] + uKIM-1 + M | 0.846 | 0.780 to 0.910 |